Congenital Junctional Ectopic Tachycardia in a 6-month-old boy treated with Ivabradine: A Case Report
DOI:
https://doi.org/10.3126/njh.v20i1.55039Keywords:
Congenital, Junctional ectopic tachycardia, IvabradineAbstract
Congenital junctional ectopic tachycardia (JET) is a rare tachyarrhythmia found in young infants and is often difficult to treat. JET is characterized by incessant tachycardia which causes ventricular dysfunction, heart failure and high mortality. Ivabradine is one of the newer antiarrhythmic drugs with special indications in decreasing heart rate in adults with chronic heart failure. It has shown promising role in congenital JET. However, there are no guidelines recommending ivabradine as a first-line agent for congenital JET. We report an infant with congenital JET who was successfully treated with ivabradine.
Downloads
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2023 Nepalese Heart Journal
This work is licensed under a Creative Commons Attribution 4.0 International License.
This license enables reusers to distribute, remix, adapt, and build upon the material in any medium or format, so long as attribution is given to the creator. The license allows for commercial use.